HQH
$16.23
abrdn Healthcare Investors
Fund Family: abrdn Healthcare Investors
1 Month
+1.12%
YTD
-8.17%
1 Year
-8.17%
3 Year
+12.66%
Top 10 Holdings (38.6% of portfolio)
| Rank | Company | Ticker | Sector | Weight |
|---|---|---|---|---|
| 1 | Gilead Sciences Inc | GILD | Manufacturing | 6.44% |
| 2 | Amgen Inc | AMGN | Manufacturing | 5.97% |
| 3 | Regeneron Pharmaceuticals Inc | REGN | Manufacturing | 5.91% |
| 4 | Vertex Pharmaceuticals Inc | VRTX | Manufacturing | 3.96% |
| 5 | Eli Lilly & Co | LLY | Manufacturing | 3.57% |
| 6 | BioMarin Pharmaceutical Inc | BMRN | Manufacturing | 2.92% |
| 7 | Alnylam Pharmaceuticals Inc | ALNY | Manufacturing | 2.77% |
| 8 | UnitedHealth Group Inc | UNH | Finance and Insurance | 2.77% |
| 9 | State Street Institutional US Government Money Market Fund | GVMXX | Unknown | 2.23% |
| 10 | Abbott Laboratories | ABT | Manufacturing | 2.05% |
Fund Information
| Net Assets | $951.18M | Expense Ratio | N/A |
| Total Holdings | 98 | Annual Fee* | N/A |
| Inception Date | N/A | Fund Family | abrdn Healthcare Investors |
*Annual fee per $10,000 invested